ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 407 filers reported holding ENCOMPASS HEALTH CORP in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,242,284 | -29.5% | 48,277 | -29.0% | 0.00% | 0.0% |
| Q2 2023 | $4,601,774 | +208.3% | 67,963 | +146.3% | 0.00% | +100.0% |
| Q1 2023 | $1,492,674 | -9.1% | 27,591 | +0.5% | 0.00% | 0.0% |
| Q4 2022 | $1,641,485 | +417.8% | 27,445 | +292.2% | 0.00% | – |
| Q3 2022 | $317,000 | -3.1% | 6,998 | +19.7% | 0.00% | – |
| Q2 2022 | $327,000 | -12.8% | 5,845 | +10.9% | 0.00% | – |
| Q1 2022 | $375,000 | +20.6% | 5,271 | +10.5% | 0.00% | – |
| Q4 2021 | $311,000 | -11.1% | 4,772 | +2.4% | 0.00% | – |
| Q3 2021 | $350,000 | +68.3% | 4,661 | +74.6% | 0.00% | – |
| Q2 2021 | $208,000 | -1.0% | 2,669 | +5.2% | 0.00% | – |
| Q4 2020 | $210,000 | -81.7% | 2,537 | -86.0% | 0.00% | -100.0% |
| Q2 2019 | $1,145,000 | +48.1% | 18,077 | +36.6% | 0.00% | – |
| Q1 2019 | $773,000 | +69.5% | 13,230 | +79.1% | 0.00% | – |
| Q4 2018 | $456,000 | +60.6% | 7,385 | +102.9% | 0.00% | – |
| Q3 2018 | $284,000 | – | 3,640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |